[PPB] QoQ Annualized Quarter Result on 30-Sep-2008 [#3]

Announcement Date
27-Nov-2008
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
30-Sep-2008 [#3]
Profit Trend
QoQ- -14.06%
YoY- -86.62%
Quarter Report
View:
Show?
Annualized Quarter Result
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Revenue 2,077,906 1,980,912 2,488,566 3,506,248 3,301,448 3,235,552 2,989,442 -21.54%
PBT 1,252,162 1,057,648 1,220,339 1,378,816 1,550,226 1,667,876 563,936 70.28%
Tax 100,926 28,076 73,085 -136,062 -109,026 -130,584 6,438,576 -93.75%
NP 1,353,088 1,085,724 1,293,424 1,242,753 1,441,200 1,537,292 7,002,512 -66.61%
-
NP to SH 1,338,734 1,087,340 1,286,509 1,230,970 1,432,442 1,532,392 6,972,965 -66.75%
-
Tax Rate -8.06% -2.65% -5.99% 9.87% 7.03% 7.83% -1,141.72% -
Total Cost 724,818 895,188 1,195,142 2,263,494 1,860,248 1,698,260 -4,013,070 -
-
Net Worth 13,456,103 13,597,677 12,234,401 11,795,221 11,368,023 11,675,481 11,428,151 11.51%
Dividend
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Div 118,555 - 1,007,678 1,059,001 1,588,441 - 355,647 -51.95%
Div Payout % 8.86% - 78.33% 86.03% 110.89% - 5.10% -
Equity
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Net Worth 13,456,103 13,597,677 12,234,401 11,795,221 11,368,023 11,675,481 11,428,151 11.51%
NOSH 1,185,559 1,185,499 1,185,504 1,185,449 1,185,403 1,185,327 1,185,492 0.00%
Ratio Analysis
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
NP Margin 65.12% 54.81% 51.97% 35.44% 43.65% 47.51% 234.24% -
ROE 9.95% 8.00% 10.52% 10.44% 12.60% 13.12% 61.02% -
Per Share
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
RPS 175.27 167.10 209.92 295.77 278.51 272.97 252.17 -21.55%
EPS 112.92 91.72 108.52 103.84 120.84 129.28 588.19 -66.75%
DPS 10.00 0.00 85.00 89.33 134.00 0.00 30.00 -51.95%
NAPS 11.35 11.47 10.32 9.95 9.59 9.85 9.64 11.51%
Adjusted Per Share Value based on latest NOSH - 1,185,607
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
RPS 146.07 139.25 174.94 246.48 232.08 227.45 210.15 -21.55%
EPS 94.11 76.44 90.44 86.53 100.69 107.72 490.17 -66.75%
DPS 8.33 0.00 70.84 74.44 111.66 0.00 25.00 -51.97%
NAPS 9.4591 9.5586 8.6003 8.2916 7.9913 8.2074 8.0335 11.51%
Price Multiplier on Financial Quarter End Date
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Date 30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 -
Price 11.60 9.80 9.30 8.55 10.80 10.20 11.00 -
P/RPS 6.62 5.86 4.43 2.89 3.88 3.74 4.36 32.13%
P/EPS 10.27 10.68 8.57 8.23 8.94 7.89 1.87 211.60%
EY 9.73 9.36 11.67 12.15 11.19 12.67 53.47 -67.92%
DY 0.86 0.00 9.14 10.45 12.41 0.00 2.73 -53.73%
P/NAPS 1.02 0.85 0.90 0.86 1.13 1.04 1.14 -7.15%
Price Multiplier on Announcement Date
30/06/09 31/03/09 31/12/08 30/09/08 30/06/08 31/03/08 31/12/07 CAGR
Date 21/08/09 19/05/09 27/02/09 27/11/08 26/08/08 29/05/08 29/02/08 -
Price 15.30 11.00 9.70 8.55 8.80 11.00 10.80 -
P/RPS 8.73 6.58 4.62 2.89 3.16 4.03 4.28 60.90%
P/EPS 13.55 11.99 8.94 8.23 7.28 8.51 1.84 278.97%
EY 7.38 8.34 11.19 12.15 13.73 11.75 54.46 -73.64%
DY 0.65 0.00 8.76 10.45 15.23 0.00 2.78 -62.08%
P/NAPS 1.35 0.96 0.94 0.86 0.92 1.12 1.12 13.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment